DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 42 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 7.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99 | +86.8% | 64,508 | +91.9% | 0.00% | – |
| Q4 2022 | $53 | -100.0% | 33,619 | -64.3% | 0.00% | -100.0% |
| Q2 2021 | $419,000 | -70.1% | 94,100 | -38.5% | 0.00% | -50.0% |
| Q1 2021 | $1,401,000 | +21.8% | 153,100 | +35.0% | 0.00% | +100.0% |
| Q4 2020 | $1,150,000 | +182.6% | 113,400 | +18.1% | 0.00% | – |
| Q3 2020 | $407,000 | -43.9% | 96,000 | -8.3% | 0.00% | -100.0% |
| Q2 2020 | $726,000 | +908.3% | 104,700 | +305.0% | 0.00% | – |
| Q1 2020 | $72,000 | – | 25,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
| Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
| Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
| Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
| COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
| Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
| MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |